Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction
R de Waal, K Cohen, G Maartens - PloS one, 2013 - journals.plos.org
Background Lipoatrophy and/or central fat gain are observed frequently in patients on
antiretroviral therapy (ART). Both are assumed to be antiretroviral adverse drug reactions …
antiretroviral therapy (ART). Both are assumed to be antiretroviral adverse drug reactions …
Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs
JB Nachega, MJ Mugavero, M Zeier… - Patient preference …, 2011 - Taylor & Francis
Since the advent of highly active antiretroviral therapy (HAART), the treatment of human
immunodeficiency virus (HIV) infection has become more potent and better tolerated. While …
immunodeficiency virus (HIV) infection has become more potent and better tolerated. While …
[HTML][HTML] HIV and HAART-associated dyslipidemia
ER Feeney, PWG Mallon - The open cardiovascular medicine …, 2011 - ncbi.nlm.nih.gov
Effective highly active antiretroviral therapy (HAART) for human immunodeficiency virus-1
(HIV) infection has led to marked improvement in life-expectancy for those infected with HIV …
(HIV) infection has led to marked improvement in life-expectancy for those infected with HIV …
Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
DV Glidden, K Mulligan, V McMahan… - Clinical Infectious …, 2018 - academic.oup.com
Background Antiretroviral drugs have been associated with changes in lipids, fat mass and
dat distribution. Tenofovir disoproxil fumarate (TDF) has been shown to have a more …
dat distribution. Tenofovir disoproxil fumarate (TDF) has been shown to have a more …
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy
JH Willig, S Abroms, AO Westfall, J Routman… - Aids, 2008 - journals.lww.com
Methods: Retrospective study of antiretroviral-naive patients starting treatment at the
University of Alabama at Birmingham 1917 HIV/AIDS Clinic 1 January 2000–31 July 2007 …
University of Alabama at Birmingham 1917 HIV/AIDS Clinic 1 January 2000–31 July 2007 …
HIV/AIDS-related knowledge among Malaysian young adults: Findings from a nationwide survey
Purpose HIV/AIDS poses a serious threat to young people, both in Malaysia and throughout
the world. A nationwide cross-sectional survey was conducted to assess the knowledge …
the world. A nationwide cross-sectional survey was conducted to assess the knowledge …
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care
HM Crane, C Grunfeld, JH Willig, MJ Mugavero… - Aids, 2011 - journals.lww.com
Objective: To assess the associations between nucleoside reverse transcriptase inhibitors
(NRTIs) and change in lipid levels among a large cohort of HIV-infected patients in routine …
(NRTIs) and change in lipid levels among a large cohort of HIV-infected patients in routine …
Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy
PDP Domingo, V Estrada, J López-Aldeguer… - … , vol. 14, num. 2, p. 112 …, 2012 - diposit.ub.edu
More than 15 years after the introduction of highly active antiretroviral therapy, HIV/HAART-
associated lipodystrophy syndrome still shadows the indisputable efficacy of antiretroviral …
associated lipodystrophy syndrome still shadows the indisputable efficacy of antiretroviral …
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy
L Calza, R Manfredi, D Pocaterra, F Chiodo - Journal of Infection, 2008 - Elsevier
The use of new potent protease inhibitor-based antiretroviral therapies in patients with
human immunodeficiency virus (HIV) infection has been increasingly associated with …
human immunodeficiency virus (HIV) infection has been increasingly associated with …
Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir …
E Ribera, JC Paradiñeiro, A Curran, S Sauleda… - HIV Clinical …, 2008 - Taylor & Francis
Background: Lipoatrophy is the most stigmatizing side effect of stavudine therapy. We
assessed the long-term effects of replacing stavudine with tenofovir in HIV-infected patients …
assessed the long-term effects of replacing stavudine with tenofovir in HIV-infected patients …